Showing results (781-790 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|February 5, 2021
Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastomaAdithya Balasubramanian, Ashray Gunjur, Umbreen Hafeez, et al.
Neuro-Oncology Advances|February 19, 2021
New developments in neurofibromatosis type 2 and vestibular schwannomaYin Ren, Divya A Chari, Sasa Vasilijic, et al.
Neuro-Oncology Advances|February 22, 2021
Phase I dose-escalation, safety, and CNS pharmacokinetic study of dexanabinol in patients with brain cancerTiffany M Juarez, David Piccioni, Lara Rose, et al.
Neuro-Oncology Advances|November 12, 2021
Identification of five important genes to predict glioblastoma subtypesYang Tang, Maleeha A Qazi, Kevin R Brown, et al.
Neuro-Oncology Advances|March 5, 2021
Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?Erlend Skaga, Marthe Andrea Skretteberg, Tom Børge Johannesen, et al.
Neuro-Oncology Advances|December 13, 2021
Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgeryXuguang Chen, Vishwa S Parekh, Luke Peng, et al.
Neuro-Oncology Advances|December 13, 2021
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytesMatteo Simonelli, Pasquale Persico, Arianna Capucetti, et al.
Neuro-Oncology Advances|November 5, 2021
Association between height and the risk of primary brain malignancy in adults: a nationwide population-based cohort studyStephen Ahn, Kyungdo Han, Jung Eun Lee, et al.
Neuro-Oncology Advances|September 8, 2022
Identifying clinically applicable machine learning algorithms for glioma segmentation: recent advances and discoveriesNiklas Tillmanns, Avery E Lum, Gabriel Cassinelli, et al.
Neuro-Oncology Advances|January 7, 2022
Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPGChristopher L Tinkle, Alberto Broniscer, Jason Chiang, et al.
Pageof 138